Preservation of the capacity to appoint a proxy decision maker implications for dementia research

Archives of General Psychiatry

Volumn 68, Issue 2, 2011, Pages 214-220

  Kim, Scott Y H ^a   Karlawish, Jason H ^c   Kim, H Myra ^a   Wall, Ian F ^a   Bozoki, Andrea C ^b   Appelbaum, Paul S ^d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Michigan State University   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); DECISION MAKING; DEMENTIA; FEMALE; HUMAN; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COMPREHENSION; DECISION MAKING; ETHICS, RESEARCH; FEMALE; HUMANS; INFORMED CONSENT; MALE; MENTAL COMPETENCY; MENTAL STATUS SCHEDULE; NEUROSURGICAL PROCEDURES; NOOTROPIC AGENTS; OBSERVER VARIATION; PATIENT SELECTION; PROXY; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79951478617     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2010.191     Document Type: Article

References (24)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M; Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366(9503):2112-2117. (Pubitemid 41797645)
2. Kim SYH, Kim HM, Langa KM, Karlawish JHT, Knopman DS, Appelbaum PS. Surrogate consent for dementia research: a national survey of older Americans. Neurology. 2009;72(2):149-155.
3. Saks ER, Dunn LB, Wimer J, Gonzales M, Kim SYH. Proxy consent to research: the legal landscape. Yale J Health Policy Law Ethics. 2008;8(1):37-92.
4. Nuffield Council on Bioethics. Dementia: ethical issues. Consultation paper. 2008. http://www.nuffieldbioethics.org/dementia. Accessed November 17, 2010.
5. Recombinant DNA Advisory Committee: minutes of meeting. Public Health Service, National Institutes of Health, US Department of Health and Human Services. September 9-10, 2008. http://oba.od.nih.gov/oba/RAC/meetings/Sept2008/ RAC-Minutes-09-08.pdf. Accessed January 27, 2010.
6. Kim SYH. Evaluation of Capacity to Consent to Treatment and Research. New York, NY: Oxford University Press; 2010.
7. National Bioethics Advisory Commission (United States). Research involving persons with mental disorders that may affect decision-making capacity. J Int Bioethique. 2002;13(3-4):173-179.
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
9. Kim SYH, Caine ED, Currier GW, Leibovici A, Ryan JM. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. Am J Psychiatry. 2001;158(5):712-717. (Pubitemid 32429837)
10. Kim SYH, Caine ED. Utility and limits of the Mini-Mental State Examination in evaluating consent capacity in Alzheimer's disease. Psychiatr Serv. 2002;53 (10):1322-1324.
11. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-198.
12. Appelbaum PS, Grisso T, Frank E, O'Donnell S, Kupfer DJ. Competence of depressed patients for consent to research. Am J Psychiatry. 1999;156(9):1380-1384. (Pubitemid 29416534)
13. Carpenter WT Jr, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry. 2000;57(6):533-538. (Pubitemid 30349432)
14. Appelbaum PS, Grisso T. MacCAT-CR: MacArthur Competence Assessment Tool for Clinical Research. Sarasota, FL: Professional Resource Press; 2001.
15. Kim SYH, Appelbaum PS, Swan J, Stroup TS, McEvoy JP, Goff DC, Jeste DV, Lamberti JS, Leibovici A, Caine ED. Determining when impairment constitutes incapacity for informed consent in schizophrenia research. Br J Psychiatry. 2007; 191(1):38-43.
16. Kim SYH, Caine ED, Swan JG, Appelbaum PS. Do clinicians follow a risksensitive model of capacity-determination? an experimental video survey. Psychosomatics. 2006;47(4):325-329.
17. Kim SYH, Appelbaum PS. The capacity to appoint a proxy and the possibility of concurrent proxy directives. Behav Sci Law. 2006;24(4):469-478. (Pubitemid 44328712)
18. Grisso T, Appelbaum PS. Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. New York, NY: Oxford University Press; 1998.
19. Carmines EG, Zeller RA. Reliability and Validity Assessment. Beverly Hills, CA: Sage Publications; 1979.
20. Kim SYH. When does decisional impairment become decisional incompetence? ethical and methodological issues in capacity research in schizophrenia. Schizophr Bull. 2006;32(1):92-97. (Pubitemid 43063822)
21. Wendler D, Martinez RA, Fairclough D, Sunderland T, Emanuel E. Views of potential subjects toward proposed regulations for clinical research with adults unable to consent. Am J Psychiatry. 2002;159(4):585-591. (Pubitemid 34274940)
22. Dukoff R, Sunderland T. Durable power of attorney and informed consent with Alzheimer's disease patients: a clinical study. Am J Psychiatry. 1997;154(8): 1070-1075. (Pubitemid 27328821)
23. Marson DC, Earnst KS, Jamil F, Bartolucci A, Harrell LE. Consistency of physicians' legal standard and personal judgments of competency in patients with Alzheimer's disease. J Am Geriatr Soc. 2000;48(8):911-918.
24. Schneider LS, Olin JT, Lyness SA, Chui HC. Eligibility of Alzheimer's disease clinic patients for clinical trials. J Am Geriatr Soc. 1997;45(8):923-928. (Pubitemid 27330120)